Charles River Q3 FY2026: organic growth returns, guidance raised
Charles River beat the $3.00 non-GAAP consensus at $3.09 and raised full-year guidance, but reported revenue still fell 2.2% to $982.7 million because of May divestitures. Strip those out and the core business grew 4.7% organically. The $6.86 GAAP figure is not the operating story: $5.06 a share came from a one-time tax reserve reversal.
1 · Expected vs. Actual
Free preview belowNon-GAAP EPS of $3.09 beat the $3.0028 consensus and rose 27.2% year over year. GAAP EPS of $6.86 is not a comparable number: it carries a $5.06 per share benefit from reversing acquired tax reserves, which turned the tax line into a $163.8 million benefit instead of a cost. On the non-GAAP basis, net income was $150.1 million, up 24.8%.
Revenue of $982.7 million was down 2.2% from $1,004.9 million, but the decline is almost entirely divestitures: the CDMO, Cell Solutions and certain European Discovery sites sales removed 7.1 points of growth. Organic growth was 4.7%, with DSA at 5.9% and Manufacturing at 7.4%. RMS was the only segment to shrink organically, at 0.6%.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-04
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.